COVID-19: More Research Needed on Maternal and Infant Health Outcomes
Pregnant individuals and newborns have immune systems that are more susceptible to viral infections than the general population.
Panel: Improving Diversity in Clinical Trials Better Serves Patients
Researchers and health care stakeholders must actively pursue more representative clinical trials and make changes that encourage the participation of…
Exploring Opportunities to Engage with NIH and FDA to Advance Research
SWHR looks forward to working with the new Congress and administration to advance women’s health, and will continue to support…
SWHR’s Endometriosis Toolkit Empowers Patients to Take Charge of Their Health
SWHR launched its new Endometriosis Toolkit: A Guide to Patient Empowerment, designed to help people of all ages with endometriosis…
SWHR Supports Bill to Improve Fibroids Education and Research Funding
SWHR endorses the Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2021, designed to improve funding for research…
Long COVID: The Impact on Women and Ongoing Research
As the end of the COVID-19 pandemic seems in sight, we are still far from fully understanding the virus and…
People of Color Continue to Be Underrepresented in Research on New Drugs
After decades of being underrepresented in biomedical research, women have accounted for more than 50% of participants in clinical trials…
Harnessing the Power of AI for All Patients Requires Focus on Equity and Transparency
It is imperative that AI developers and regulators consider race, ethnicity, and gender in their datasets to work toward improved…
Maternal Health Disparities: A Q&A with Dr. Jasmine Johnson
SWHR CEO Katie Schubert interviews Dr. Jasmine Johnson, a maternal-fetal medicine fellow at the University of North Carolina, about racial…